03:25 PM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target of $142, up $8, reflects a combination of our EV/EBITDA and DCF models. On a relative basis, we apply a 7x multiple of enterprise value to projected 2026 EBITDA. The applied multiple is a slight premium to XOM's historical forward average, but predicated on structural cost improvements that should boost earnings power even with flat pricing. That approach yields a value of $124 per share. Our DCF model, using free cash flow growth of 3% for 10 years, 2% thereafter, and discounted at a WACC of 6.7%, shows intrinsic value of $161 per share. We lift our 2025 EPS estimate by $0.05 to $7.17 and 2026's by $0.15 to $8.53. XOM continues to offer upstream growth drivers in the Permian and offshore Guyana, and its Energy Products and Chemicals segments generated sequential improvements. XOM's balance sheet remains a fortress, with net debt to capital under 10%. The company boosted the quarterly dividend by 4% to a revised $1.03 per share, or an annualized yield of 3.6%.